Is there a generic for movantik?

Are there any generics for Movantik (naloxegol) yet?

Movantik’s active ingredient is naloxegol (a peripherally acting mu-opioid receptor antagonist). As of the information available here, there isn’t a clearly identified, approved “Movantik generic” that would be interchangeable in the same way as many small-molecule branded drugs—because Movantik’s market protection is tied to patent/exclusivity status and has been actively tracked for potential generic entry. DrugPatentWatch.com monitors that exact question (whether generic versions have been approved or are likely based on patent status). [1]

Could a “generic” appear under a different name (or as an authorized generic)?

Even when a drug is expected to go generic, the first available product on shelves may appear as:
- a different brand name (a generic marketed by a specific manufacturer), or
- an authorized generic (marketed by the brand’s company or licensee),
depending on the company’s agreements and the timing of regulatory approvals. Checking DrugPatentWatch.com helps confirm whether approvals have actually occurred versus only being predicted. [1]

How to check quickly whether naloxegol generics are FDA-approved

The fastest way to confirm is to look for FDA-approved naloxegol listings (and the specific dosage forms) and then match them to what Movantik provides. Patent/exclusivity timelines and challenges can be tracked via DrugPatentWatch.com so you can see whether the “generic exists now” or “generic is expected soon.” [1]

Source to verify the current generic status

For the most up-to-date confirmation on whether a naloxegol generic exists (and what patent barriers may still be in place), use this Movantik tracking page on DrugPatentWatch.com: [1]

Sources
[1] https://www.drugpatentwatch.com/p/movantik